Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Pelvis Cancer”

165 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 165 results

Testing effectiveness (Phase 2)Looking for participantsNCT04724018
What this trial is testing

Sacituzumab Govitecan Plus EV in Metastatic UC

Who this might be right for
Urothelial CancerMetastatic Urothelial CarcinomaMetastatic Urothelial Carcinoma of the Renal Pelvis and Ureter+1 more
Dana-Farber Cancer Institute 106
Early research (Phase 1)Study completedNCT01182168
What this trial is testing

Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Bladder CancerRenal Pelvis CancerUreter Cancer
Memorial Sloan Kettering Cancer Center 12
Not applicableStudy completedNCT01138124
What this trial is testing

Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)

Who this might be right for
Renal Pelvis CancerRestless Legs SyndromeEpilepsy+7 more
GlaxoSmithKline 54,202
Testing effectiveness (Phase 2)Study completedNCT01090466
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Cardiff University 15
Testing effectiveness (Phase 2)Study completedNCT00006111
What this trial is testing

Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
UNICANCER 53
Testing effectiveness (Phase 2)Study completedNCT00002914
What this trial is testing

Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group 40
Not applicableAvailableNCT05494411
What this trial is testing

Named Patient Program for Mitomycin for Pyelocalyceal Solution

Who this might be right for
Urothelial Cancer of Renal PelvisUrothelial Carcinoma of the Renal Pelvis and UreterUrothelial Carcinoma Ureter+3 more
UroGen Pharma Ltd.
Not applicableLooking for participantsNCT06652009
What this trial is testing

Radical Radiotherapy Versus Radical Surgery for UTUC

Who this might be right for
Renal Pelvis Cancer
Peking University First Hospital 60
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Looking for participantsNCT04865939
What this trial is testing

Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma

Who this might be right for
Urothelial Cancer of Renal PelvisUrothelial Carcinoma Ureter
University of Texas Southwestern Medical Center 132
Not applicableLooking for participantsNCT06040762
What this trial is testing

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

Who this might be right for
Bladder CancerUrothelial CarcinomaUpper Tract Urothelial Carcinoma+1 more
University of Washington 128
Not applicableLooking for participantsNCT06926374
What this trial is testing

Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery

Who this might be right for
Colorectal CarcinomaRectal ProlapseProstate Cancer (Adenocarcinoma)+7 more
Chinese University of Hong Kong 90
Testing effectiveness (Phase 2)Study completedNCT00006376
What this trial is testing

R115777 in Treating Patients With Advanced Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Post-approval studies (Phase 4)Study completedNCT02812186
What this trial is testing

Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery

Who this might be right for
CholecystitisEndometriosisBowel Obstruction+4 more
Stony Brook University 79
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT03662204
What this trial is testing

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors

Who this might be right for
Breast CancerLung CancerColorectal Cancer+10 more
Exact Sciences Corporation 5,133
Not applicableNot Yet RecruitingNCT06427993
What this trial is testing

Urine DNA Methylation Detection for Hematuria Evaluation

Who this might be right for
HematuriaUrothelial CarcinomaBladder Cancer+2 more
Changhai Hospital 71
Testing effectiveness (Phase 2)WithdrawnNCT03935347
What this trial is testing

Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis Urothelial CarcinomaMetastatic Ureter Urothelial Carcinoma+3 more
Roswell Park Cancer Institute
Not applicableStudy completedNCT02430779
What this trial is testing

Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms

Who this might be right for
Renal Pelvic and Ureteral Neoplasms
Fuda Cancer Hospital, Guangzhou 30
Load More Results